Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric F Johnson

Showing results (101-110 of 122) with videos related to

Pageof 13
Sort By:
Journal of Medicinal Chemistry|July 21, 2006
Discovery of potent, highly selective, and orally bioavailable pyridine carboxamide c-Jun NH2-terminal kinase inhibitorsHongyu Zhao, Michael D Serby, Zhili Xin, et al.
Angewandte Chemie (International Ed. in English)|August 18, 2017
Determinants of the Inhibition of DprE1 and CYP2C9 by Antitubercular ThiophenesRenhe Liu, Xiaoxuan Lyu, Sarah M Batt, et al.
Bioorganic & Medicinal Chemistry Letters|January 13, 2006
Discovery of trans-3,4'-bispyridinylethylenes as potent and novel inhibitors of protein kinase B (PKB/Akt) for the treatment of cancer: Synthesis and biological evaluationQun Li, Tongmei Li, Gui-Dong Zhu, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2006
Synthesis and structure-activity relationship of 3,4'-bispyridinylethylenes: discovery of a potent 3-isoquinolinylpyridine inhibitor of protein kinase B (PKB/Akt) for the treatment of cancerQun Li, Keith W Woods, Sheela Thomas, et al.
Journal of Bacteriology|September 27, 2012
Complete genome sequence of Desulfurococcus fermentans, a hyperthermophilic cellulolytic crenarchaeon isolated from a freshwater hot spring in Kamchatka, RussiaDwi Susanti, Eric F Johnson, Jason R Rodriguez, et al.
Journal of Medicinal Chemistry|December 21, 2016
Aminomethyl-Derived Beta Secretase (BACE1) Inhibitors: Engaging Gly230 without an Anilide FunctionalityChristopher R Butler, Kevin Ogilvie, Luis Martinez-Alsina, et al.
Bioorganic & Medicinal Chemistry|July 18, 2006
Synthesis and SAR of indazole-pyridine based protein kinase B/Akt inhibitorsKeith W Woods, John P Fischer, Akiyo Claiborne, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2009
2,4-Diaminopyrimidine MK2 inhibitors. Part II: Structure-based inhibitor optimizationChristopher M Harris, Anna M Ericsson, Maria A Argiriadi, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2010
Imidazo[2,1-b]thiazoles: multitargeted inhibitors of both the insulin-like growth factor receptor and members of the epidermal growth factor family of receptor tyrosine kinasesSteve D Fidanze, Scott A Erickson, Gary T Wang, et al.
Anticancer Research|November 28, 2008
The PARP inhibitor, ABT-888 potentiates temozolomide: correlation with drug levels and reduction in PARP activity in vivoJoann P Palma, Luis E Rodriguez, Velitchka D Bontcheva-Diaz, et al.
Pageof 13

Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
Journal of Medicinal Chemistry|July 21, 2006
Discovery of potent, highly selective, and orally bioavailable pyridine carboxamide c-Jun NH2-terminal kinase inhibitorsHongyu Zhao, Michael D Serby, Zhili Xin, et al.
Angewandte Chemie (International Ed. in English)|August 18, 2017
Determinants of the Inhibition of DprE1 and CYP2C9 by Antitubercular ThiophenesRenhe Liu, Xiaoxuan Lyu, Sarah M Batt, et al.
Bioorganic & Medicinal Chemistry Letters|January 13, 2006
Discovery of trans-3,4'-bispyridinylethylenes as potent and novel inhibitors of protein kinase B (PKB/Akt) for the treatment of cancer: Synthesis and biological evaluationQun Li, Tongmei Li, Gui-Dong Zhu, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2006
Synthesis and structure-activity relationship of 3,4'-bispyridinylethylenes: discovery of a potent 3-isoquinolinylpyridine inhibitor of protein kinase B (PKB/Akt) for the treatment of cancerQun Li, Keith W Woods, Sheela Thomas, et al.
Journal of Bacteriology|September 27, 2012
Complete genome sequence of Desulfurococcus fermentans, a hyperthermophilic cellulolytic crenarchaeon isolated from a freshwater hot spring in Kamchatka, RussiaDwi Susanti, Eric F Johnson, Jason R Rodriguez, et al.
Journal of Medicinal Chemistry|December 21, 2016
Aminomethyl-Derived Beta Secretase (BACE1) Inhibitors: Engaging Gly230 without an Anilide FunctionalityChristopher R Butler, Kevin Ogilvie, Luis Martinez-Alsina, et al.
Bioorganic & Medicinal Chemistry|July 18, 2006
Synthesis and SAR of indazole-pyridine based protein kinase B/Akt inhibitorsKeith W Woods, John P Fischer, Akiyo Claiborne, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2009
2,4-Diaminopyrimidine MK2 inhibitors. Part II: Structure-based inhibitor optimizationChristopher M Harris, Anna M Ericsson, Maria A Argiriadi, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2010
Imidazo[2,1-b]thiazoles: multitargeted inhibitors of both the insulin-like growth factor receptor and members of the epidermal growth factor family of receptor tyrosine kinasesSteve D Fidanze, Scott A Erickson, Gary T Wang, et al.
Anticancer Research|November 28, 2008
The PARP inhibitor, ABT-888 potentiates temozolomide: correlation with drug levels and reduction in PARP activity in vivoJoann P Palma, Luis E Rodriguez, Velitchka D Bontcheva-Diaz, et al.
Pageof 13